Clinical Study
Transcatheter Mitral Valve Repair in Surgical High-Risk Patients: Gender-Specific Acute and Long-Term Outcomes
Table 1
Baseline patient characteristics.
| | All patients () | Men () | Women () | value |
| Age (years) | 75.0 ± 8.7 | 74.4 ± 8.4 | 76.0 ± 9.2 | 0.029 | Body mass index (kg/m2) | 25.5 ± 4.5 | 25.8 ± 4.1 | 25.0 ± 4.9 | 0.031 | Logistic EuroSCORE | 21.0 (11.8–33.1) | 22.9 (12.2–35.9) | 19.5 (11.3–29.4) | 0.020 | STS score | 4.3 (2.7–7) | 4.4 (2.7–7.8) | 4.1 (2.7–6.1) | 0.21 | Cardiovascular risk factors | | | | | Hypertension No. (%) | 424 (71.9) | 254 (70.4) | 170 (74.2) | 0.35 | Hypercholesterolemia No. (%) | 242 (41.5) | 160 (44.8) | 82 (36.3) | 0.051 | Diabetes mellitus No. (%) | 164 (27.9) | 119 (32.9) | 45 (19.9) | <0.001 | Nicotine abuse No. (%) | 152 (41.3) | 112 (51.1) | 40 (26.8) | <0.001 | Comorbidities | | | | | Cardiomyopathy No. (%) | 422 (73.4) | 286 (80.6) | 136 (61.8) | <0.001 | Dilated | 147 (25.6) | 83 (23.4) | 64 (29.1) | 0.15 | Ischemic | 270 (47.0) | 200 (56.3) | 70 (31.8) | <0.001 | None | 153 (26.6) | 69 (19.4) | 84 (38.2) | <0.001 | Coronary artery disease No. (%) | 381 (64.6) | 266 (73.5) | 115 (50.4) | <0.001 | Previous myocardial infarction No. (%) | 195 (33.2) | 145 (40.4) | 50 (21.8) | <0.001 | Previous percutaneous intervention No. (%) | 238 (40.6) | 166 (46.2) | 72 (31.7) | <0.001 | Previous coronary artery bypass grafting No. (%) | 179 (30.3) | 146 (40.3) | 33 (14.4) | <0.001 | Chronic obstructive pulmonary disease No. (%) | 120 (20.4) | 79 (21.9) | 41 (18.0) | 0.29 | Renal failure No. (%) | 335 (57.0) | 230 (63.9) | 105 (46.1) | <0.001 | Atrial fibrillation No. (%) | 398 (67.6) | 250 (69.3) | 148 (64.9) | 0.31 | Stroke No. (%) | 94 (16.0) | 66 (18.3) | 28 (12.3) | 0.068 | Peripheral artery disease No. (%) | 56 (9.7) | 40 (11.3) | 16 (7.1) | 0.13 | Device | | | | | CRT No. (%) | 119 (20.2) | 86 (23.8) | 33 (14.5) | 0.0091 |
|
|
STS = Society of Thoracic Surgeons, CRT = cardiac resynchronization therapy, and No. = number.
|